BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26439718)

  • 21. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved high sensitivity screen for Huntington disease using a one-step triplet-primed PCR and melting curve assay.
    Zhao M; Cheah FSH; Chen M; Lee CG; Law HY; Chong SS
    PLoS One; 2017; 12(7):e0180984. PubMed ID: 28700716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease.
    Nance MA; Mathias-Hagen V; Breningstall G; Wick MJ; McGlennen RC
    Neurology; 1999 Jan; 52(2):392-4. PubMed ID: 9932964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR.
    González-González MC; Trujillo MJ; Rodríguez de Alba M; Ramos C
    Neurology; 2003 Apr; 60(7):1214-5. PubMed ID: 12682342
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
    Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
    J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile onset Huntington disease resulting from a very large maternal expansion.
    Nahhas FA; Garbern J; Krajewski KM; Roa BB; Feldman GL
    Am J Med Genet A; 2005 Sep; 137A(3):328-31. PubMed ID: 16096998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-onset Huntington disease with intermediate CAG repeats: true or false?
    Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of capillary electrophoresis for accurate determination of CAG repeats causing Huntington disease. An oligonucleotide design avoiding shadow bands.
    Blanco S; Suarez A; Gandia-Pla S; Gómez-Llorente C; Antúnez A; Gómez-Capilla JA; Fárez-Vidal ME
    Scand J Clin Lab Invest; 2008; 68(7):577-84. PubMed ID: 19378429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion of a (CAG)n repeat region in a sporadic case of HD.
    Bozza A; Malagù S; Calzolari E; Novelletto A; Pavoni M; del Senno L
    Acta Neurol Scand; 1995 Aug; 92(2):132-4. PubMed ID: 7484060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avoiding errors in the diagnosis of (CAG)n expansion in the huntingtin gene.
    Holzmann C; Saecker AM; Epplen JT; Riess O
    J Med Genet; 1997 Mar; 34(3):264. PubMed ID: 9132504
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical characteristics of Huntington disease in two pedigrees and analysis of expanded CAG trinucleotide repeat].
    Cao GN; Bao XH; Lu HM; Zhang JJ; Ma YN; Gu WH; Xiong H; Qin J; Wu XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):163-7. PubMed ID: 21503105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA testing for Huntington disease in the Turkish population.
    Akbas F; Erginel-Unaltuna N
    Eur Neurol; 2003; 50(1):20-4. PubMed ID: 12824708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease.
    Alford RL; Ashizawa T; Jankovic J; Caskey CT; Richards CS
    Am J Med Genet; 1996 Dec; 66(3):281-6. PubMed ID: 8985488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles.
    Semaka A; Creighton S; Warby S; Hayden MR
    Clin Genet; 2006 Oct; 70(4):283-94. PubMed ID: 16965319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
    Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
    J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.
    Ramos EM; Gillis T; Mysore JS; Lee JM; Alonso I; Gusella JF; Smoller JW; Sklar P; MacDonald ME; Perlis RH
    Bipolar Disord; 2015 Jun; 17(4):403-8. PubMed ID: 25726852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biallelic mutations in huntington disease: A new case with just one affected parent, review of the literature and terminology.
    Uhlmann WR; Peñaherrera MS; Robinson WP; Milunsky JM; Nicholson JM; Albin RL
    Am J Med Genet A; 2015 May; 167A(5):1152-60. PubMed ID: 25736541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
    Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
    Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the association of genotype and phenotype features of the pathogenesis of Huntington's chorea].
    Hryshchenko NV; Kucherenko AM; Patskun EI; Livshyts' LA
    Tsitol Genet; 2009; 43(3):42-7. PubMed ID: 19938636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.